换一批Non-targeted and chiral amino acid metabolomics of colon cancer:Revealing novel chiral biomarkers and metabolic pathways
摘要Colorectal cancer(CRC),the third most commonly diagnosed malignancy worldwide,is associated with a high mortality rate[1].Current blood-based detection of carcinoembryonic antigen(CEA)lacks sufficient sensitivity and specificity for early CRC diagnosis,often resulting in detection at advanced stages[2].Metabolomics-driven differential metabolite profiling offers insights into CRC pathogenesis and may facilitate the discovery of novel clinical biomarkers[3].
更多相关知识
栏目名称
DOI
10.1016/j.jpha.2025.101429
发布时间
2026-06-18（万方平台首次上网日期，不代表论文的发表时间）
- 浏览1
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
